PortfoliosLab logoPortfoliosLab logo
ISIN
US74265M2052
CUSIP
74265M205
IPO Date
Aug 18, 1995

Highlights

Market Cap
$210.57M
Enterprise Value
$224.10M
EPS (TTM)
$3.62
PE Ratio
17.79
PEG Ratio
0.21
Total Revenue (TTM)
$74.64M
Gross Profit (TTM)
$20.73M
EBITDA (TTM)
$16.82M
Year Range
$23.47 - $68.99
ROA (TTM)
16.01%
ROE (TTM)
26.55%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

PDEX Performance Chart

Pro-Dex, Inc. (PDEX) is up 67.4% since the beginning of the year. At $64 per share, PDEX is trading 6.7% below its 52-week high of $69. Investors who bought $1,000 worth of PDEX shares 5 years ago would now be looking at an investment worth $2,194.


Loading charts...

S&P 500 Index

Returns By Period

Pro-Dex, Inc. (PDEX) has returned 67.36% so far this year and 58.86% over the past 12 months. Looking at the last ten years, PDEX has achieved an annualized return of 28.94%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.


Pro-Dex, Inc.

1D
0.05%
1M
1.39%
YTD
67.36%
6M
50.89%
1Y
58.86%
3Y*
49.82%
5Y*
17.02%
10Y*
28.94%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PDEX Monthly Returns History

Based on dividend-adjusted daily data since Aug 18, 1995, PDEX's average daily return is +0.13%, while the average monthly return is +1.74%. At this rate, an investment would double in approximately 3.3 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2018 with a return of +65.9%, while the worst month was Apr 2001 at -41.1%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, PDEX closed higher 42% of trading days. The best single day was Sep 18, 2002 with a return of +71.1%, while the worst single day was Oct 11, 2002 at -40.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20261.95%12.95%10.86%2.08%29.18%-0.57%67.36%
2025-18.78%-8.56%42.80%32.47%-39.03%8.98%14.69%-6.33%-27.79%7.06%0.55%5.60%-17.69%
202422.83%-20.54%2.92%5.11%6.54%-0.36%2.95%15.38%27.95%3.92%64.41%-8.33%166.84%
20238.36%-10.21%6.08%-3.11%19.50%0.53%-5.76%-5.50%-7.70%8.28%-4.94%8.42%10.19%
20225.77%-24.40%-10.94%-8.65%5.89%-0.25%0.38%19.93%-7.71%9.42%-9.18%-9.71%-31.50%
2021-0.03%-20.38%9.33%5.83%19.85%-10.59%0.39%-17.86%1.87%-5.45%-7.09%2.93%-25.06%

Benchmark Metrics

Pro-Dex, Inc. has an annualized alpha of 33.34%, beta of 0.49, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since August 18, 1995.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (39.96%) than losses (31.22%) - typical of diversified or defensive assets.
  • Beta of 0.49 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
33.34%
Beta
0.49
0.02
Upside Capture
39.96%
Downside Capture
31.22%

Return for Risk

Risk / Return Rank

PDEX ranks 67 for risk / return — better than 67% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


PDEX Risk / Return Rank: 6767
Overall Rank
PDEX Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
PDEX Sortino Ratio Rank: 6666
Sortino Ratio Rank
PDEX Omega Ratio Rank: 6868
Omega Ratio Rank
PDEX Calmar Ratio Rank: 6464
Calmar Ratio Rank
PDEX Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Pro-Dex, Inc. (PDEX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PDEXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.11

Sortino ratioReturn per unit of downside risk

-1.28

Omega ratioGain probability vs. loss probability

1.21

1.37

-0.16

Calmar ratioReturn relative to maximum drawdown

1.07

2.78

-1.72

Martin ratioReturn relative to average drawdown

2.46

12.44

-9.98

Dividends

Dividend History


Pro-Dex, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Pro-Dex, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Pro-Dex, Inc. was 95.50%, occurring on Mar 3, 2009. Recovery took 2753 trading sessions.

The current Pro-Dex, Inc. drawdown is 6.67%.


Related event

Drawdown

Fall

Recovery

Underwater

Financial crisis2007–2009
-95.50%Mar 2009
12y 9mo10y 11mo
23y 8moMay 1996 - Feb 2020
Bear market2022
-69.11%May 2022
1y 4mo2y 6mo
3y 10moDec 2020 - Nov 2024
2025 bear market2025
-65.36%Oct 2025
5mo 20d
1y 1moApr 2025 - now
2025 selloff2025
-44.62%Feb 2025
1mo 15d1mo 17d
3mo 2dJan 2025 - Apr 2025
COVID crash2020
-36.90%Mar 2020
15d4mo 23d
5mo 8dMar 2020 - Aug 2020

Drawdown Indicators


PDEXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-95.50%

-56.78%

-38.72%

Max Drawdown (1Y)

Largest decline over 1 year

-55.32%

-9.10%

-46.22%

Max Drawdown (3Y)

Largest decline over 3 years

-65.36%

-18.90%

-46.46%

Max Drawdown (5Y)

Largest decline over 5 years

-65.36%

-25.43%

-39.93%

Max Drawdown (10Y)

Largest decline over 10 years

-69.11%

-33.92%

-35.19%

Current Drawdown

Current decline from peak

-6.67%

-1.80%

-4.87%

Average Drawdown

Average peak-to-trough decline

-63.65%

-10.71%

-52.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.96%

2.03%

+21.93%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Pro-Dex, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Pro-Dex, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PDEX, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, PDEX has a P/E ratio of 17.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for PDEX compared to other companies in the Medical Instruments & Supplies industry. PDEX currently has a PEG ratio of 0.2. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PDEX relative to other companies in the Medical Instruments & Supplies industry. Currently, PDEX has a P/S ratio of 2.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PDEX in comparison with other companies in the Medical Instruments & Supplies industry. Currently, PDEX has a P/B value of 4.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with PDEX

Add Pro-Dex, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with PDEX